US Patent Issued to Harmony Biosciences Management on Aug. 25 for "Treatment of 22Q11.2 deletion syndrome with cannabidiol" (Pennsylvania, North Carolina Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,718, issued on Aug. 25, was assigned to Harmony Biosciences Management Inc. (Plymouth Meeting, Pa.).

"Treatment of 22Q11.2 deletion syndrome with cannabidiol" was invented by Terri Sebree (Gladwyne, Pa.) and Donna Gutterman (Raleigh, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present technology relates to methods of treating one or more behavioral symptoms (for example, anxiety) of 22q11.2 deletion syndrome in a subject by administering, e.g., transdermally, an effective amount of cannabidiol (CBD) to the subject wherein one or more behavioral and/or psychiatric symptoms of 22q11.2 deletion syndrome are treated in the subject."

The pat...